These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1604797)

  • 21. Intranasal immunization with liposomes induces strong mucosal immune responses in mice.
    Vadolas J; Davies JK; Wright PJ; Strugnell RA
    Eur J Immunol; 1995 Apr; 25(4):969-75. PubMed ID: 7737300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroral immunization of microencapsulated human VP8 in combination with cholera toxin induces intestinal antibody responses.
    Kang DK; Kim PH; Ko EJ; Seo JY; Seong SY; Kim YH; Kwon IC; Jeong SY; Yang JM
    Mol Cells; 1999 Dec; 9(6):609-16. PubMed ID: 10672927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cholera toxin as a mucosal adjuvant: III. Antibody responses to nontarget dietary antigens are not increased.
    Nedrud JG; Sigmund N
    Reg Immunol; 1990-1991; 3(5):217-22. PubMed ID: 1966580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen.
    Elson CO; Ealding W
    J Immunol; 1984 Dec; 133(6):2892-7. PubMed ID: 6491278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence-inhibitory intestinal immunoglobulin a antibody response in baboons elicited by use of a synthetic intranasal lectin-based amebiasis subunit vaccine.
    Abd Alla MD; White GL; Rogers TB; Cary ME; Carey DW; Ravdin JI
    Infect Immun; 2007 Aug; 75(8):3812-22. PubMed ID: 17526742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of nasal clearance of nontypeable Haemophilus influenzae by oral immunization with outer membrane proteins.
    Suzuki M; Kurono Y; Kodama S; Shigemi H; Mogi G
    Acta Otolaryngol; 1998 Nov; 118(6):864-9. PubMed ID: 9870635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered serum immunoglobulin response to model intestinal antigens during dietary exposure to vomitoxin (deoxynivalenol).
    Pestka JJ; Moorman MA; Warner RL
    Toxicol Lett; 1990 Jan; 50(1):75-84. PubMed ID: 2296780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal and systemic adjuvant effects of cholera toxin and Cry1Ac protoxin on the specific antibody response to HIV-1 C4/V3 peptides are different and depend on the antigen co-administered.
    Esquivel-Pérez R; Moreno-Fierros L
    Viral Immunol; 2005; 18(4):695-708. PubMed ID: 16359236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kefir milk enhances intestinal immunity in young but not old rats.
    Thoreux K; Schmucker DL
    J Nutr; 2001 Mar; 131(3):807-12. PubMed ID: 11238763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody response in mice immunized by mucosal routes with formalin-inactivated enteropathogenic Escherichia coli (EPEC) strains.
    Drago-Serrano ME; Manjarréz Hernandez HA; Gavilanes Parra S; Sainz Espuñes Tdel R
    Rev Latinoam Microbiol; 2004; 46(1-2):17-23. PubMed ID: 17061522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative evaluation of nasal and parenteral vaccine adjuvants to elicit systemic and mucosal HIV-1 peptide-specific humoral immune responses in cynomolgus macaques.
    Egan MA; Chong SY; Hagen M; Megati S; Schadeck EB; Piacente P; Ma BJ; Montefiori DC; Haynes BF; Israel ZR; Eldridge JH; Staats HF
    Vaccine; 2004 Sep; 22(27-28):3774-88. PubMed ID: 15315859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunopotentiation of Staphylococcus aureus type 5 capsular polysaccharide co-entrapped in liposomes with alpha-toxin.
    Burgeot C; Gilbert FB; Poutrel B
    Vaccine; 2001 Feb; 19(15-16):2092-9. PubMed ID: 11228381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant effect of cholera toxin on systemic and mucosal immune responses in chickens infected with E. tenella or given recombinant parasitic antigen per os.
    Girard F; Péry P; Naciri M; Quéré P
    Vaccine; 1999 Mar; 17(11-12):1516-24. PubMed ID: 10195788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant cholera toxin B subunit acts as an adjuvant for the mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin.
    Tochikubo K; Isaka M; Yasuda Y; Kozuka S; Matano K; Miura Y; Taniguchi T
    Vaccine; 1998; 16(2-3):150-5. PubMed ID: 9607023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Murine IgG subclass antibodies to antigens incorporated in liposomes containing lipid A.
    Glenn GM; Rao M; Richards RL; Matyas GR; Alving CR
    Immunol Lett; 1995; 47(1-2):73-8. PubMed ID: 8537104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of specific IgE antibody responses by liposome-conjugated ovalbumin in mice sensitized with ovalbumin via the respiratory tract.
    Yoshikawa T; Uchida T; Naito S; Horino A; Taneichi M; Kato H; Komuro K; Nakano Y; Mori M; Nishinohara S; Chiba J; Kurata T; Tamura S
    Int Arch Allergy Immunol; 2000 Feb; 121(2):108-15. PubMed ID: 10705220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Kozuka S; Taniguchi T; Matano K; Maeyama J; Komiya T; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 1999 Nov; 18(7-8):743-51. PubMed ID: 10547435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitized liposomes as an antigen delivery system for the stimulation of mucosal immunity.
    Velez CN; Tonkonogy SL; Lichtman SN; Cho MJ
    J Drug Target; 1997; 5(1):15-24. PubMed ID: 9524310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of sulphasalazine on antibody response to oral antigen.
    Sheldon P; Pell P; McBurney A
    Br J Rheumatol; 1992 Dec; 31(12):819-22. PubMed ID: 1360861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.